These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7911057)

  • 1. Concentration/effect relationship of bunazosin, a selective alpha 1-adrenoceptor antagonist in hypertensive patients after single and multiple oral doses.
    Harder S; Thürmann P
    Int J Clin Pharmacol Ther; 1994 Jan; 32(1):38-43. PubMed ID: 7911057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of essential hypertension with the alpha-1 antagonist bunazosin retard. A multicenter, double-blind, placebo-controlled study].
    Kirsten R; Weidinger G
    Arzneimittelforschung; 1994 Jan; 44(1):13-6. PubMed ID: 7907871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dose-response study of bunazosin in the treatment of light-to-moderate arterial hypertension].
    Marchegiano R; Lamenza F; Sarno D; Tozzi N; Fontana D; De Luca N
    Minerva Cardioangiol; 1993 Oct; 41(10):451-6. PubMed ID: 7905614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of the alpha 1-adrenergic antagonist bunazosin retard in hypertensives.
    Shionoiri H; Minamisawa M; Ueda S; Minamisawa K; Takizawa T; Takasaki I; Sugimoto K; Gotoh E; Ishii M
    Arzneimittelforschung; 1994 Nov; 44(11):1191-5. PubMed ID: 7848330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration/effect relationship and enantioselective analysis of verapamil in hypertensive patients.
    Harder S; Thürmann P; Siewert M; Blume H; Rietbrock N; vander Kleijn J; Gierend M
    J Cardiovasc Pharmacol; 1992 May; 19(5):665-9. PubMed ID: 1381762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic properties and therapeutic use of bunazosin in hypertension. A review.
    Weidinger G
    Arzneimittelforschung; 1995 Nov; 45(11):1166-71. PubMed ID: 8929232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alpha-1 blockers for therapy of essential hypertension. 2 clinical studies with bunazosin].
    Meyer U; Schmidt J
    Fortschr Med; 1998 May; 116(14):43-4. PubMed ID: 9648395
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronopharmacological study of bunazosin hydrochloride in healthy subjects.
    Kumagai Y; Fujimura A; Nakashima H; Shitoh T; Sugimoto K; Oribe H; Ebihara A
    Int J Clin Pharmacol Res; 1989; 9(5):335-40. PubMed ID: 2576246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardura XL--a unique drug formulation--doxazosine administered in a slow-release form (doxazosine GITS)].
    Grzeszczak W
    Przegl Lek; 2000; 57(11):643-54. PubMed ID: 11293213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between terazosin dose and blood pressure response in hypertensive patients.
    Achari R; Hosmane B; Bonacci E; O'Dea R
    J Clin Pharmacol; 2000 Oct; 40(10):1166-72. PubMed ID: 11028256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topically instilled bunazosin, an alpha1-adrenoceptor antagonist, on constrictions induced by phenylephrine and ET-1 in rabbit retinal arteries.
    Ichikawa M; Okada Y; Asai Y; Hara H; Ishii K; Araie M
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4041-8. PubMed ID: 15505054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bunazosin on plasma glucose levels in hypertensive diabetic patients.
    Takeda N; Iwai T; Tanamura A; Nagano M
    Clin Ther; 1989; 11(5):568-71. PubMed ID: 2572324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationship of prizidilol hydrochloride (SK&F 92657): a comparison between acute and chronic effects in patients with essential hypertension.
    Pedrinelli R; Abdel-Haq B; Magagna A; Leto di Priolo S; Simonini N; Salvetti A
    Int J Clin Pharmacol Res; 1984; 4(2):155-63. PubMed ID: 6147320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
    Harder S; Rietbrock S; Thürmann P
    Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.